How GLP-1s are accelerating dairy protein demand

A man's hand places an injection pen containing medication into home refrigerator next to food items. Concept of home-based treatment, medication storage, and use of drugs requiring refrigeration
GLP-1s are reshaping the dairy sector. (Image: Getty/NATALIA KHIMICH)

Dairy companies such as Danone, Arla, Yili and Saputo have pointed out the importance of the weight-loss drugs to protein demand


GLP-1s and dairy protein demand: Overview

  • GLP-1 users increasingly seek protein-rich foods in smaller portions
  • Whey proteins remain foremost beneficiaries of GLP-1-driven demand growth
  • Manufacturers often use milk protein concentrates alongside whey ingredients
  • Dairy companies cite GLP-1s as accelerating existing protein trends
  • GLP-1s support demand growth without solely driving dairy markets

The rise of GLP-1s has had a profound impact on demand for dairy proteins.

With users of the drugs requiring more nutrient-dense foods – essentially, more nutrients crammed into smaller portions – high-protein products have become particularly relevant for these consumers.

Explore related questions

This demand was not caused by GLP-1s – dairy ingredients companies such as Fonterra observe high-protein demand stemming from a variety of factors – but they are an important part of it.

Which dairy proteins are GLP-1s driving demand for?

Whey proteins are “at the forefront” of GLP-1-driven demand, says Tom Booijink, senior dairy specialist for Europe and Africa at Rabobank. In particular, whey protein isolate and whey protein concentrate are seeing demand.

Indeed, whey shortages have happened in part due to pressure exerted by GLP-1 users, says Jasper Endlich, dairy market analyst at commodity analytics company Vesper.

Whey has long been popular with gym goers and bodybuilders, Booijink points out, but now it has become more mainstream. GLP-1s have accelerated this trend.

GLP-1 users need extra protein to mitigate the impact of muscle loss, which is often a side-effect of GLP-1 use. Whey, says Booijink, given its nutritional quality and amino acid profile (meaning that it is absorbed quickly), is particularly well-suited to GLP-1 users.

However, the GLP-1 boom is not the only factor in boosting whey demand, as the market was tight before GLP-1 use took off.

Manufacturers are also looking at alternatives to whey, including milk protein concentrates, which contain about 80% casein and 20% whey. Using these, manufacturers can still claim to have added whey, Booijink says.

Around 90% of products with added protein ingredients use milk protein concentrate, says Randy Steenbergen, senior market intelligence analyst at market intelligence platform Valona Intelligence.

However, whey is more prominent in products such as gels, bars and snacks, where performance, convenience and protein density matter most.

How dairy proteins are used in food

Enrichment of products with milk proteins is no longer confined to sports nutrition, says Booijink, having migrated into products such as bars, RTD drinks, desserts, yoghurts and even the foam on hot drinks.

As well as dairy proteins, GLP-1s are leading consumers towards a range of dairy-based foods, such as kefir and skyr, says Jemma Milne, senior nutrition scientist at ingredients company Arla Foods.

“Dairy foods can offer high-quality protein alongside a range of naturally occurring vitamins and minerals, making them a useful way of adding nutrient density to the diet.”

How is GLP-1 affecting demand for dairy as a whole?

“GLP-1s have not created the dairy protein boom, but they have certainly put a thumb on the scale of an already tight market,” says Rabobank’s Booijink. GLP-1s are a “very powerful catalyst” of demand, but not the “sole driver”.

The level of impact that GLP-1s have had is difficult to quantify precisely, he admits.

Yet it is clearly seen as a driver by industry. Companies including Arla, Yili and Saputo have stressed the importance of GLP-1 as a driver for demand, explains Steenbergen. “On a company level ... a lot of agendas in dairy are centred around whey and protein.”

GLP-1s are a key part of the drive for high-protein products, says a spokesperson for Danone, particularly because users are preoccupied with maintaining muscle mass.

Nevertheless, points out Steenbergen, products with explicit GLP-1-friendly claims are still rare in European retail. For most products, suitability for GLP-1 users is only implicit.

GLP-1s are a major part of dairy protein demand

The dairy sector was already focused on protein before the advent of GLP-1s, with broad-based consumer demand edging towards it.

Yet GLP-1s have accelerated this trend, with the drug’s users requiring the nutrient density that proteins like whey can provide them, especially to reduce muscle loss.

GLP-1 demand is not at the centre of the dairy protein story, but it is an important character.